1. Home
  2. NTCT vs BHVN Comparison

NTCT vs BHVN Comparison

Compare NTCT & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTCT
  • BHVN
  • Stock Information
  • Founded
  • NTCT 1984
  • BHVN 2013
  • Country
  • NTCT United States
  • BHVN United States
  • Employees
  • NTCT N/A
  • BHVN N/A
  • Industry
  • NTCT EDP Services
  • BHVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTCT Technology
  • BHVN Health Care
  • Exchange
  • NTCT Nasdaq
  • BHVN Nasdaq
  • Market Cap
  • NTCT 1.6B
  • BHVN 1.4B
  • IPO Year
  • NTCT 1999
  • BHVN 2017
  • Fundamental
  • Price
  • NTCT $22.25
  • BHVN $13.50
  • Analyst Decision
  • NTCT Hold
  • BHVN Strong Buy
  • Analyst Count
  • NTCT 1
  • BHVN 14
  • Target Price
  • NTCT $25.00
  • BHVN $58.85
  • AVG Volume (30 Days)
  • NTCT 744.9K
  • BHVN 1.6M
  • Earning Date
  • NTCT 08-07-2025
  • BHVN 08-07-2025
  • Dividend Yield
  • NTCT N/A
  • BHVN N/A
  • EPS Growth
  • NTCT N/A
  • BHVN N/A
  • EPS
  • NTCT N/A
  • BHVN N/A
  • Revenue
  • NTCT $822,679,000.00
  • BHVN N/A
  • Revenue This Year
  • NTCT $3.89
  • BHVN $3.00
  • Revenue Next Year
  • NTCT $2.40
  • BHVN $59.97
  • P/E Ratio
  • NTCT N/A
  • BHVN N/A
  • Revenue Growth
  • NTCT N/A
  • BHVN N/A
  • 52 Week Low
  • NTCT $17.96
  • BHVN $13.04
  • 52 Week High
  • NTCT $27.89
  • BHVN $55.70
  • Technical
  • Relative Strength Index (RSI)
  • NTCT 37.49
  • BHVN 42.74
  • Support Level
  • NTCT $22.29
  • BHVN $13.30
  • Resistance Level
  • NTCT $23.27
  • BHVN $14.09
  • Average True Range (ATR)
  • NTCT 0.56
  • BHVN 0.82
  • MACD
  • NTCT -0.10
  • BHVN 0.05
  • Stochastic Oscillator
  • NTCT 11.90
  • BHVN 19.74

About NTCT NetScout Systems Inc.

NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: